Diagnostic Delay in Adolescents with Cancer During COVID-19 Pandemic: A New Price for Our Patients to Pay.


Journal

Journal of adolescent and young adult oncology
ISSN: 2156-535X
Titre abrégé: J Adolesc Young Adult Oncol
Pays: United States
ID NLM: 101543508

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 23 10 2021
medline: 11 6 2022
entrez: 22 10 2021
Statut: ppublish

Résumé

Worldwide, the coronavirus 19 disease pandemic caused a worse chance of a timely diagnosis for cancer patients. We conducted a retrospective analysis of new diagnoses registered in the national pediatric oncology database, comparing the first lockdown period (March-May 2020) with the same period of 2015-2019. The total number of cases (0-19 years) dropped by 20.8% (from 441 between 2015 and 2019 to 349 in 2020). A major reduction was observed for adolescents (15-19 years) (-32.9%) and for adolescents with solid tumors (-56.4%,

Identifiants

pubmed: 34677087
doi: 10.1089/jayao.2021.0057
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

316-319

Auteurs

Paola Quarello (P)

Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Department, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Regina Margherita Children's Hospital, Torino, Italy.
University of Torino, Torino, Italy.

Andrea Ferrari (A)

Pediatric Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.

Maurizio Mascarin (M)

AYA and Pediatric Radiotherapy Department, Centro di Riferimento Oncologico IRCCS, Aviano, Italy.

Giuseppe M Milano (GM)

Department of Pediatric Hematology and Oncology and of Cell and Gene Therapy, Scientific Institute for Research and Healthcare (IRCCS), Bambino Gesù Childrens' Hospital, Rome, Italy.

Assunta Tornesello (A)

Pediatric Oncology Department, Ospedale Vito Fazzi, Lecce, Italy.

Marina Bertolotti (M)

Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Department, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Regina Margherita Children's Hospital, Torino, Italy.

Marco Spinelli (M)

Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy.

Marta Pierobon (M)

Hematology and Oncology Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy.

Teresa Perillo (T)

Pediatric Hematology-Oncology Division, Department of Pediatrics, University of Bari, Bari, Italy.

Milena Maule (M)

Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Marco Zecca (M)

Pediatric/Hematology/Oncology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Andrea Pession (A)

Pediatric Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Franca Fagioli (F)

Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Department, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Regina Margherita Children's Hospital, Torino, Italy.
University of Torino, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH